Literature DB >> 11744549

Funding medicines for people with multiple sclerosis.

D Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11744549      PMCID： PMC1121848          DOI： 10.1136/bmj.323.7326.1379

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Health department to fund interferon beta despite institute's ruling.

Authors:  S Mayor
Journal:  BMJ       Date:  2001-11-10

Review 2.  Interferon-beta therapy in multiple sclerosis: evidence for a clinically relevant dose response.

Authors:  D S Goodin
Journal:  Drugs       Date:  2001       Impact factor: 9.546
  2 in total
  2 in total

1.  Rehabilitation services remain important in multiple sclerosis.

Authors:  Richard Richards
Journal:  BMJ       Date:  2002-04-20

2.  Setting up an outcomes guarantee for pharmaceuticals: new approach to risk sharing in primary care.

Authors:  Stephen Chapman; Elly Reeve; Giri Rajaratnam; Richard Neary
Journal:  BMJ       Date:  2003-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.